Valuation: McKesson Corporation

Market Cap 99.88B 86.27B 81.07B 73.72B 139B 9,551B 141B 950B 371B 4,783B 375B 367B 15,894B P/E 2027 *
21.9x
P/E 2028 * 17.5x
Enterprise Value 104B 89.74B 84.33B 76.7B 144B 9,936B 147B 988B 386B 4,976B 390B 382B 16,534B EV / Sales 2027 *
0.24x
EV / Sales 2028 * 0.22x
Free-Float
41.53%
Yield 2027 *
0.42%
Yield 2028 * 0.44%
1 day-1.02%
1 week-1.87%
Current month-1.34%
1 month+4.07%
3 months+14.99%
6 months-5.81%
Current year+3.63%
1 week 736.6
Extreme 736.6
776
1 month 689.2
Extreme 689.2
776
Current year 611.6
Extreme 611.6
865.8
1 year 573.6
Extreme 573.6
865.8
3 years 378
Extreme 378
865.8
5 years 167.75
Extreme 167.75
865.8
10 years 95.04
Extreme 95.04
865.8
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2019
Chief Tech/Sci/R&D Officer 53 03/10/2023
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 70 24/04/2018
Chairman 59 01/05/2026
Director/Board Member 68 12/09/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-1.87% - - 99.88B
+1.11%-0.42%+28.51%+97.70% 99.88B
+0.90%-1.42%+55.14%+150.61% 53.78B
0.00%-0.33%+4.20%+272.50% 24.2B
-1.13%+0.97%-12.64%-13.95% 8.32B
+0.54%+6.83%-31.49%-24.63% 7.69B
-0.24%-2.34%-13.61%-22.51% 6.66B
+1.24%+2.26%+9.25%+19.91% 6.23B
+0.31%-1.34%-6.08%+19.44% 4.96B
-0.59%+2.22%-6.12%-4.61% 3.76B
Average +0.18%-1.05%+3.02%+54.94% 23.94B
Weighted average by Cap. +0.20%-1.62%+25.44%+112.31%

Financials

2027 *2028 *
Net sales 432B 373B 351B 319B 599B 41,301B 609B 4,107B 1,606B 20,682B 1,622B 1,586B 68,731B 463B 399B 375B 341B 642B 44,226B 652B 4,398B 1,720B 22,147B 1,736B 1,699B 73,597B
Net income 4.69B 4.05B 3.81B 3.46B 6.51B 449B 6.62B 44.61B 17.44B 225B 17.61B 17.23B 746B 5.62B 4.85B 4.56B 4.15B 7.8B 537B 7.93B 53.45B 20.9B 269B 21.1B 20.64B 894B
Net Debt 4.03B 3.48B 3.27B 2.97B 5.59B 385B 5.68B 38.28B 14.97B 193B 15.11B 14.79B 641B 2.72B 2.35B 2.21B 2.01B 3.78B 260B 3.84B 25.88B 10.12B 130B 10.22B 9.99B 433B
Logo McKesson Corporation
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.
Employees
42,300
Date Price Change Volume
14/08/26 EUR 736.60 -2.67% 0
13/08/26 EUR 756.80 -2.40% 0
12/08/26 EUR 775.40 +2.48% 1
11/08/26 EUR 756.60 +1.29% 0
10/08/26 EUR 747.00 -0.48% 0
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
856.69USD
Average target price
991.40USD
Spread / Average Target
+15.72%

Quarterly revenue - Rate of surprise